CD274 and melanoma: Additionally, recent phase 1 evaluation of the Wnt/β-catenin signaling pathway within melanoma has shown that overactivation of the Wnt pathway conveys resistance to immunotherapy with anti-PD-L1 monoclonal antibody [28], a treatment that has been recently extrapolated for use in gynecologic tumors [29,30].